AARDAardvark Therapeutics, Inc.
- Market cap
- $30.42M
- as of 2026-10-23
- Latest close
- $1.39
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2025-02-19
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Zhang Zhongwei | Oct 7 | Oct 8 | A · derivative | 127,061 | $4.96 | $630,223 | 127,061 | No | Form 4 |
| Sun NelsonSee Remarks | Sep 11 | Sep 11 | S | 62,000 | $5.18 | Sale −$321,160 | 35,475 | Yes | Form 4 |
| Sun NelsonSee Remarks | Sep 10 | Sep 11 | S | 14,754 | $5.00 | Sale −$73,770 | 97,475 | Yes | Form 4 |
| Tong Victor Edward Jr | Aug 14 | Aug 21 | A · derivative | 44,964 | $6.54 | $294,065 | 44,964 | No | Form 4 |
| Baynes Roy D. | Aug 14 | Aug 21 | A · derivative | 44,964 | $6.54 | $294,065 | 44,964 | No | Form 4 |
| Graf Susan E | Aug 14 | Aug 21 | A · derivative | 44,964 | $6.54 | $294,065 | 44,964 | No | Form 4 |
| Chi Jeffrey | Aug 14 | Aug 21 | A · derivative | 44,964 | $6.54 | $294,065 | 44,964 | No | Form 4 |
| Jaiman ManasiChief Medical Officer | Feb 9 | Feb 11 | A · derivative | 70,549 | $13.48 | $951,001 | 70,549 | No | Form 4 |
| Lee Tien-LiChief Executive Officer | Feb 9 | Feb 11 | A · derivative | 203,851 | $13.48 | $2,747,911 | 203,851 | No | Form 4 |
| Sun NelsonChief Financial Officer | Feb 9 | Feb 11 | A · derivative | 70,549 | $13.48 | $951,001 | 70,549 | No | Form 4 |
| Lee Tien-LiChief Executive Officer | Dec 11, 2025 | Dec 12, 2025 | P | 7,000 | $14.49 | Purchase +$101,430 | 1,551,613 | No | Form 4 |
| Sun NelsonChief Financial Officer | Dec 11, 2025 | Dec 12, 2025 | P | 3,000 | $14.40 | Purchase +$43,200 | 108,484 | No | Form 4 |
| Jones BryanChief Operating Officer | Oct 15, 2025 | Oct 16, 2025 | M | 1,250 | $4.24 | $5,300 | 1,250 | No | Form 4 |
| Jones BryanChief Operating Officer | Oct 15, 2025 | Oct 16, 2025 | M · derivative | 1,250 | $4.24 | $5,300 | 40,052 | No | Form 4 |
| Lee Tien-LiChief Executive Officer | Oct 15, 2025 | Oct 16, 2025 | M | 1,229 | $4.24 | $5,211 | 1,544,613 | No | Form 4 |
| Lee Tien-LiChief Executive Officer | Oct 15, 2025 | Oct 16, 2025 | M · derivative | 1,229 | $4.24 | $5,211 | 40,566 | No | Form 4 |
| Lee Tien-LiChief Executive Officer | Sep 15, 2025 | Sep 16, 2025 | P | 6,500 | $9.51 | Purchase +$61,815 | 1,539,884 | No | Form 4 |
| Lee Tien-LiChief Executive Officer | Sep 15, 2025 | Sep 16, 2025 | P | 3,500 | $9.94 | Purchase +$34,790 | 1,543,384 | No | Form 4 |
| Lee Tien-LiChief Executive Officer | Sep 12, 2025 | Sep 12, 2025 | P | 5,000 | $8.50 | Purchase +$42,500 | 1,533,384 | No | Form 4 |
| Lee Tien-LiChief Executive Officer | Sep 11, 2025 | Sep 12, 2025 | P | 6,000 | $7.82 | Purchase +$46,920 | 1,528,384 | No | Form 4 |
| Lee Tien-LiChief Executive Officer | Sep 10, 2025 | Sep 12, 2025 | P | 9,000 | $7.91 | Purchase +$71,190 | 1,522,384 | No | Form 4 |
| Sun NelsonChief Financial Officer | Sep 9, 2025 | Sep 10, 2025 | P | 6,000 | $8.07 | Purchase +$48,420 | 105,484 | No | Form 4 |
| Lee Tien-LiChief Executive Officer | Aug 28, 2025 | Aug 29, 2025 | M | 17,209 | $4.24 | $72,966 | 1,513,384 | No | Form 4 |
| Lee Tien-LiChief Executive Officer | Aug 28, 2025 | Aug 29, 2025 | M · derivative | 17,209 | $4.24 | $72,966 | 41,795 | No | Form 4 |
| Graf Susan E | Jun 11, 2025 | Jun 13, 2025 | A · derivative | 30,508 | $11.29 | $344,435 | 30,508 | No | Form 4 |
| Jones BryanChief Operating Officer | Jun 11, 2025 | Jun 13, 2025 | A · derivative | 122,033 | $11.29 | $1,377,753 | 122,033 | No | Form 4 |
| Tong Victor Edward Jr | Jun 11, 2025 | Jun 13, 2025 | A · derivative | 61,017 | $11.29 | $688,882 | 61,017 | No | Form 4 |
| Baynes Roy D. | Jun 11, 2025 | Jun 13, 2025 | A · derivative | 30,508 | $11.29 | $344,435 | 30,508 | No | Form 4 |
| Sun NelsonChief Financial Officer | Jun 11, 2025 | Jun 13, 2025 | A · derivative | 209,826 | $11.29 | $2,368,936 | 209,826 | No | Form 4 |
| Jaiman ManasiChief Medical Officer | Jun 11, 2025 | Jun 13, 2025 | A · derivative | 126,999 | $11.29 | $1,433,819 | 126,999 | No | Form 4 |
| Chi Jeffrey | Jun 11, 2025 | Jun 13, 2025 | A · derivative | 61,017 | $11.29 | $688,882 | 61,017 | No | Form 4 |
| Lee Tien-LiChief Executive Officer | Jun 11, 2025 | Jun 13, 2025 | A · derivative | 549,534 | $11.29 | $6,204,239 | 549,534 | No | Form 4 |
| Chen Bihua | Feb 14, 2025 | Feb 19, 2025 | C | 800,189 | not reported | not reported | 800,189 | No | Form 4 |
| Chen Bihua | Feb 14, 2025 | Feb 19, 2025 | P | 187,500 | $16.00 | Purchase +$3,000,000 | 987,689 | No | Form 4 |
| Chen Bihua | Feb 14, 2025 | Feb 19, 2025 | C · derivative | 6,780,810 | not reported | not reported | not reported | No | Form 4 |
| Sun NelsonChief Financial Officer | Feb 14, 2025 | Feb 19, 2025 | C | 7,001 | not reported | not reported | 89,484 | No | Form 4 |
| Sun NelsonChief Financial Officer | Feb 14, 2025 | Feb 19, 2025 | P | 10,000 | $16.00 | Purchase +$160,000 | 99,484 | No | Form 4 |
| Sun NelsonChief Financial Officer | Feb 14, 2025 | Feb 19, 2025 | C · derivative | 59,332 | $0.00 | $0 | not reported | No | Form 4 |
| Lee Tien-LiChief Executive Officer | Feb 14, 2025 | Feb 19, 2025 | C | 41,303 | not reported | not reported | 1,479,633 | No | Form 4 |
| Lee Tien-LiChief Executive Officer | Feb 14, 2025 | Feb 19, 2025 | P | 16,542 | $16.00 | Purchase +$264,672 | 1,496,175 | No | Form 4 |
| Lee Tien-LiChief Executive Officer | Feb 14, 2025 | Feb 19, 2025 | C · derivative | 350,002 | $0.00 | $0 | not reported | No | Form 4 |
| Vickers Venture Fund VI Pte Ltd | Feb 14, 2025 | Feb 19, 2025 | C | 1,637,411 | not reported | not reported | 1,637,411 | No | Form 4 |
| Vickers Venture Fund VI Pte Ltd | Feb 14, 2025 | Feb 19, 2025 | C | 413,491 | not reported | not reported | 2,050,902 | No | Form 4 |
| Vickers Venture Fund VI Pte Ltd | Feb 14, 2025 | Feb 19, 2025 | C · derivative | 13,875,429 | $0.00 | $0 | not reported | No | Form 4 |
| Vickers Venture Fund VI Pte Ltd | Feb 14, 2025 | Feb 19, 2025 | C · derivative | 3,503,919 | $0.00 | $0 | not reported | No | Form 4 |
| Chi Jeffrey | Feb 14, 2025 | Feb 19, 2025 | C | 133,364 | not reported | not reported | 133,364 | No | Form 4 |
| Chi Jeffrey | Feb 14, 2025 | Feb 19, 2025 | C · derivative | 1,130,135 | $0.00 | $0 | not reported | No | Form 4 |
| Decheng Capital Global Life Sciences Fund IV, L.P. | Feb 14, 2025 | Feb 19, 2025 | C | 2,333,887 | not reported | not reported | 2,333,887 | No | Form 4 |
| Decheng Capital Global Life Sciences Fund IV, L.P. | Feb 14, 2025 | Feb 19, 2025 | C | 333,412 | not reported | not reported | 333,412 | No | Form 4 |
| Decheng Capital Global Life Sciences Fund IV, L.P. | Feb 14, 2025 | Feb 19, 2025 | P | 625,000 | $16.00 | Purchase +$10,000,000 | 2,958,887 | No | Form 4 |
| Decheng Capital Global Life Sciences Fund IV, L.P. | Feb 14, 2025 | Feb 19, 2025 | P | 625,000 | $16.00 | Purchase +$10,000,000 | 958,412 | No | Form 4 |
| Decheng Capital Global Life Sciences Fund IV, L.P. | Feb 14, 2025 | Feb 19, 2025 | C · derivative | 19,777,363 | $0.00 | $0 | not reported | No | Form 4 |
| Decheng Capital Global Life Sciences Fund IV, L.P. | Feb 14, 2025 | Feb 19, 2025 | C · derivative | 2,825,337 | $0.00 | $0 | not reported | No | Form 4 |